GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 2,088.00
-27.00 (-1.28%)
Mar 5, 2026, 2:45 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 84.79 billion as of March 5, 2026. Its market cap has increased by 43.57% in one year.
Market Cap
84.79B
Enterprise Value
98.68B
Revenue
32.67B
Ranking
n/a
PE Ratio
15.24
Stock Price
2,088.00
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 64.68B to 84.79B, an increase of 31.08%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 84.79B | 15.83% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 236.55B |
| Haleon | 35.62B |
| Smith & Nephew | 11.16B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 2.75B |
| Genus | 1.93B |
| HUTCHMED (China) | 1.76B |
| Oxford Nanopore Technologies | 1.11B |